<h1>Guest Lecture </br>
    Drug Inspection, Pharmaceutical Audits, Regulatory Compliances and Quality Risk Management</h1>
<hr/>
<h2>E Brochure-</h2>
<img src="./images/E-Brochure.png" alt="E-Brochure"/>
<h2>Organizers:</h2>
<h3>Organizer:</h3> SGT College of Pharmacy, SGT University, Gurugram
<h3>Guest Speaker:</h3> Mr. Sudipta Dey, Ex Deputy Drug Controller, CDSCO (HQ), Former Technical Advisor, Indian Pharmacopoeia Commission 
<h3>Convener:</h3> Prof. (Dr) Vijay Bhalla
<h3>Organizers:</h3> Dr. Ravi Kant, Dr. Bindiya Chauhan, Dr Manvi Singh,
Mr. Prabhat
<h3>Student's Coordinator:</h3> Vidushi, Ishita, Neha
<h2>Objective of the Workshop:</h2>
The objective of the lecture " Drug Inspection, Pharmaceutical Audits, Regulatory Compliances and Quality Risk Management" was to provide pharmacy students with a comprehensive understanding of quality risk management (QRM) practices within the pharmaceutical sector. The session aimed to elucidate the strategies and tools used to identify, assess, and mitigate risks to ensure the safety and efficacy of pharmaceutical products. Additionally, the lecture sought to offer students a unique perspective by sharing real-life experiences and challenges faced by a drug inspector in India, thereby highlighting the critical role of regulatory authorities in maintaining industry standards and protecting public health.
<h2>Brief Profile of the Guest Speaker</h2>
<li>Professionally qualified (M.Pharm. in Pharmaceutics, Gold Medalist) and experienced (around 36 years) Drugs Regulatory Official with experience in Manufacturing, Sale and distribution sector & legal affairs with specialized knowledge of Regulatory Laws and Indian as well as WHO-GMP issues.</li>
<li>Worked as Deputy Drugs Controller (India) at CDSCO (HQ), Kotla Road, New Delhi since February 2014 and retired on 31 October2017 on superannuation.</li>
<li>Worked as a Technical Advisor in Indian Pharmacopoeia Commission, Ghaziabad since January 2018 to April, 2019 after superannuation.</li>
<li>28 years’ experience as Drugs Inspector and Licensing Authority, in the inspection and reporting on WHO-GMP (CoPPs), Grant of Licenses/renewals of Allopathic Drugs manufacturing units at Delhi, Cosmetics manufacturing, Sales and Distribution outlets, Blood Banks, Enforcement and Legal/Prosecution matters relating to spurious/substandard drugs, cosmetics etc.</li>
<li>Approved as Technical Staff from Directorate of Drugs Control, West Bengal with approx. 5 years’ experience for Mfg. in Commissioning & Production of LVPs, Bulk Drugs, and Tablets.</li>
<li>Experienced in working in both State as well as Central Drugs Regulatory Authorities.</li>
<li>Well conversant and experienced in the interpretation of relevant provisions of Drugs and Cosmetics Act and Rules related to Allopathic, AYUSH drugs, Cosmetics and Blood Banks.</li>
<li>Expertise in Joint Inspection of many AYUSH manufacturers across India for issuance of COPPs in respect of Ayurvedic drugs for export.</li>
<li>Regular Presenter at different Forums, Universities and Pharmacy Colleges on the relevant topics like GMP, Quality Assurance, Spurious and Substandard Drugs, E-Pharmacy Regulation matters, Cosmetics Regulation etc.</li>
<p>Present engagement: -</p>
<li>Consultancy offered to Ayurvedic drug manufacturers for issuance of WHO-GMP/ Certificates of International Commerce (CoPPs).</li>
<li>Making presentations at Webinars organized by different Pharmacy colleges and Universities on relevant topics of Drug Regulatory Issues.</li>

<h3>Report of the Event:</h3>
<p>The Event was organised by the Quality Assurance department under aegis of SGT College of Pharmacy, SGT University, Gurugram. The program was started with welcome and felicitation of Guest Speaker Mr Sudipta Dey, followed by the welcome address by the Principal and Dean Dr Vijay Bhalla who enlightened and motivated the students and faculties on the topic of “Drug Inspection, Pharmaceutical Audits, Regulatory Compliances and Quality Risk Management” who emphasized the importance of understanding QRM and the critical role of regulatory authorities in ensuring pharmaceutical safety and efficacy. Dr. Vijay Bhalla highlighted how the insights from this lecture would be invaluable for students as they prepare for their future careers in the pharmaceutical field.</p>
<p>Mr Sudipta began the lecture by explaining the fundamental principles of quality risk management. He described QRM as a systematic process for the assessment, control, communication, and review of risks to the quality of pharmaceutical products. The lecturer detailed the key components of QRM, including risk assessment, risk control, and risk review, and illustrated how these components integrate into the overall quality management system.</p>
<p>To bring these concepts to life, Mr Sudipta shared several real-world examples and case studies. One particularly impactful case study involved a major pharmaceutical company that faced significant challenges due to inadequate risk management practices, resulting in a product recall. This case study underscored the importance of proactive risk management and the implementation of robust QRM systems to prevent such incidents.</p>
<p>A significant portion of the lecture was dedicated to the lecturer's experiences as a drug inspector in India. Mr Sudipta recounted various challenges and successes encountered while inspecting pharmaceutical manufacturing facilities. He highlighted the stringent regulatory standards that must be adhered to and shared anecdotes about uncovering non-compliance issues, addressing them, and ensuring corrective actions were taken. These stories provided students with a realistic view of the complexities and responsibilities involved in regulatory inspections.</p>
<p>During the Q&A session, students actively engaged with the speaker, posing questions about specific QRM methodologies, the role of emerging technologies in risk management, and the day-to-day responsibilities of a drug inspector. Mr Sudipta provided comprehensive answers, offering practical advice and encouraging students to consider careers in regulatory affairs and quality assurance.</p>
<p>The lecture concluded with a vote of thanks from Dr. Ravi Kant who expressed profound gratitude to Mr Sudipta for his invaluable insights and engaging presentation. Dr. Ravi Kant also commended the students for their active participation and emphasized the importance of integrating QRM principles into their future professional practices.</p>
<p>In summary, the guest lecture on “Drug Inspection, Pharmaceutical Audits, Regulatory Compliances and Quality Risk Management” was a resounding success. It provided pharmacy students with a thorough understanding of QRM and its application in the pharmaceutical industry while offering a unique perspective on the regulatory challenges and responsibilities of a drug inspector. The event not only enriched the students' knowledge but also inspired many to consider careers in quality assurance and regulatory affairs, underscoring the critical importance of these roles in ensuring pharmaceutical quality and safety.</p>
    
<h2>Some Glimpses of the Event</h2>
<img src="./images/1.png" alt="1"/>
<img src="./images/2.png" alt="2"/>
<img src="./images/3.png" alt="3"/>
<img src="./images/4.png" alt="4"/>
<img src="./images/5.png" alt="5"/>
<img src="./images/6.png" alt="6"/>
<img src="./images/7.png" alt="7"/>
<img src="./images/8.png" alt="8"/>
<img src="./images/9.png" alt="9"/>
<h2>List of Participants</h2>
<img src="./images/bpharm.png" alt="bpharm"/>
<img src="./images/mpharm.png" alt="mpharm"/>